Submitted by Anonymous (not verified) on 24 November 2025 - 16:45
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised